Analysts Come Out Bullish On Radius Health, Shares Rally

Early Wednesday morning, four analyst firms issued notes initiating bullish coverage on Radius Health RDUS.

Shares of Radius Health have shot up nearly six percent on the news. The firms respective ratings and price targets are listed below.

• Canaccord Genuity - Buy, $21
• Cowen & Company - Outperform, N/A
• Cantor Fitzgerald - Buy, $20
• Jefferies - Buy, $17

The average of these price targets is $19.33, which represents 53 percent upside to last check price of $12.62.